17-14207172-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001303.4(COX10):​c.1291C>T​(p.Arg431Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00362 in 1,608,756 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0038 ( 14 hom. )

Consequence

COX10
NM_001303.4 missense

Scores

1
7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5O:1

Conservation

PhyloP100: 0.807
Variant links:
Genes affected
COX10 (HGNC:2260): (cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10) Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes heme A:farnesyltransferase, which is not a structural subunit but required for the expression of functional COX and functions in the maturation of the heme A prosthetic group of COX. This protein is predicted to contain 7-9 transmembrane domains localized in the mitochondrial inner membrane. A gene mutation, which results in the substitution of a lysine for an asparagine (N204K), is identified to be responsible for cytochrome c oxidase deficiency. In addition, this gene is disrupted in patients with CMT1A (Charcot-Marie-Tooth type 1A) duplication and with HNPP (hereditary neuropathy with liability to pressure palsies) deletion. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006960273).
BP6
Variant 17-14207172-C-T is Benign according to our data. Variant chr17-14207172-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 445971.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3, not_provided=1, Benign=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00211 (321/152348) while in subpopulation NFE AF= 0.00385 (262/68034). AF 95% confidence interval is 0.00347. There are 1 homozygotes in gnomad4. There are 145 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COX10NM_001303.4 linkuse as main transcriptc.1291C>T p.Arg431Trp missense_variant 7/7 ENST00000261643.8 NP_001294.2 Q12887-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COX10ENST00000261643.8 linkuse as main transcriptc.1291C>T p.Arg431Trp missense_variant 7/71 NM_001303.4 ENSP00000261643.3 Q12887-1

Frequencies

GnomAD3 genomes
AF:
0.00211
AC:
321
AN:
152230
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00385
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00286
AC:
694
AN:
242974
Hom.:
3
AF XY:
0.00281
AC XY:
372
AN XY:
132428
show subpopulations
Gnomad AFR exome
AF:
0.000521
Gnomad AMR exome
AF:
0.000901
Gnomad ASJ exome
AF:
0.000203
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00138
Gnomad FIN exome
AF:
0.00147
Gnomad NFE exome
AF:
0.00521
Gnomad OTH exome
AF:
0.00201
GnomAD4 exome
AF:
0.00377
AC:
5496
AN:
1456408
Hom.:
14
Cov.:
32
AF XY:
0.00370
AC XY:
2679
AN XY:
724414
show subpopulations
Gnomad4 AFR exome
AF:
0.000777
Gnomad4 AMR exome
AF:
0.000851
Gnomad4 ASJ exome
AF:
0.000269
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00140
Gnomad4 FIN exome
AF:
0.00152
Gnomad4 NFE exome
AF:
0.00452
Gnomad4 OTH exome
AF:
0.00317
GnomAD4 genome
AF:
0.00211
AC:
321
AN:
152348
Hom.:
1
Cov.:
33
AF XY:
0.00195
AC XY:
145
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.000649
Gnomad4 AMR
AF:
0.000653
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00103
Gnomad4 FIN
AF:
0.00104
Gnomad4 NFE
AF:
0.00385
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00291
Hom.:
0
Bravo
AF:
0.00216
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00385
AC:
33
ExAC
AF:
0.00347
AC:
421
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00403

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3Other:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024COX10: BP4, BS2 -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJul 06, 2017- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 21, 2023- -
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 11, 2020This variant is associated with the following publications: (PMID: 22592081) -
not provided, no classification providedin vitroJohnston Lab, North Central College-- -
Leigh syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Mitochondrial complex IV deficiency, nuclear type 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 25, 2019- -
COX10-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 28, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T
Eigen
Uncertain
0.24
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.82
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.0070
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Uncertain
2.2
M
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.21
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
0.99
D
Vest4
0.26
MVP
0.35
MPC
0.66
ClinPred
0.028
T
GERP RS
4.6
Varity_R
0.16
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113058506; hg19: chr17-14110489; API